Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karen Cimon is active.

Publication


Featured researches published by Karen Cimon.


Journal of Telemedicine and Telecare | 2010

Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis:

Julie Polisena; Khai Tran; Karen Cimon; Brian Hutton; Sarah McGill; Krisan Palmer; Richard E. Scott

We conducted a systematic review of the literature about home telehealth for chronic obstructive pulmonary disease (COPD) compared with usual care. An electronic literature search identified 6241 citations. From these, nine original studies (10 references) relating to 858 patients were selected for inclusion in the review. Four studies compared home telemonitoring with usual care, and six randomized controlled trials compared telephone support with usual care. Clinical heterogeneity was present in many of the outcomes measured. Home telehealth (home telemonitoring and telephone support) was found to reduce rates of hospitalization and emergency department visits, while findings for hospital bed days of care varied between studies. However, the mortality rate was greater in the telephone-support group compared with usual care (risk ratio = 1.21; 95% CI: 0.84 to 1.75). Home telehealth interventions were similar or better than usual care for quality of life and patient satisfaction outcomes.


Journal of Telemedicine and Telecare | 2010

Home telemonitoring for congestive heart failure: a systematic review and meta-analysis

Julie Polisena; Khai Tran; Karen Cimon; Brian Hutton; Sarah McGill; Krisan Palmer; Richard E. Scott

We conducted a systematic review of the literature about home telemonitoring compared with usual care. An electronic literature search was conducted to identify studies of home telemonitoring use in congestive heart failure (CHF) patients. Twenty-one original studies on home telemonitoring for patients with CHF were included (3082 patients). A random effects model was used to compute treatment efficacy to measure the average effect of the intervention across all studies where the quantitative pooling of results was appropriate. Home telemonitoring reduced mortality (risk ratio = 0.64; 95% CI: 0.48–0.85) compared with usual care. Several studies suggested that home telemonitoring also helped to lower the number of hospitalizations and the use of other health services. Patient quality of life and satisfaction with home telemonitoring were similar or better than with usual care. More studies of higher methodological quality are required to give more precise information about the potential clinical effectiveness of home telehealth interventions.


Diabetes, Obesity and Metabolism | 2009

Home telehealth for diabetes management: a systematic review and meta-analysis.

Julie Polisena; Khai Tran; Karen Cimon; Brian Hutton; S. McGill; K. Palmer

Aim: It is estimated that more than 180 million people worldwide have diabetes. Health‐care providers can remotely deliver health services to this patient population using information and communication technology, also known as home telehealth. Home telehealth may be classified into two subtypes: home telemonitoring (HTM) and telephone support (TS). The research objective was to systematically review the literature and perform meta‐analyses to assess the potential benefits of home telehealth compared with usual care (UC) for patients with diabetes.


PLOS ONE | 2012

Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review.

Khai Tran; Karen Cimon; Melissa Severn; Carmem L Pessoa-Silva; John Conly

Aerosol generating procedures (AGPs) may expose health care workers (HCWs) to pathogens causing acute respiratory infections (ARIs), but the risk of transmission of ARIs from AGPs is not fully known. We sought to determine the clinical evidence for the risk of transmission of ARIs to HCWs caring for patients undergoing AGPs compared with the risk of transmission to HCWs caring for patients not undergoing AGPs. We searched PubMed, EMBASE, MEDLINE, CINAHL, the Cochrane Library, University of York CRD databases, EuroScan, LILACS, Indian Medlars, Index Medicus for SE Asia, international health technology agencies and the Internet in all languages for articles from 01/01/1990 to 22/10/2010. Independent reviewers screened abstracts using pre-defined criteria, obtained full-text articles, selected relevant studies, and abstracted data. Disagreements were resolved by consensus. The outcome of interest was risk of ARI transmission. The quality of evidence was rated using the GRADE system. We identified 5 case-control and 5 retrospective cohort studies which evaluated transmission of SARS to HCWs. Procedures reported to present an increased risk of transmission included [n; pooled OR(95%CI)] tracheal intubation [n = 4 cohort; 6.6 (2.3, 18.9), and n = 4 case-control; 6.6 (4.1, 10.6)], non-invasive ventilation [n = 2 cohort; OR 3.1(1.4, 6.8)], tracheotomy [n = 1 case-control; 4.2 (1.5, 11.5)] and manual ventilation before intubation [n = 1 cohort; OR 2.8 (1.3, 6.4)]. Other intubation associated procedures, endotracheal aspiration, suction of body fluids, bronchoscopy, nebulizer treatment, administration of O2, high flow O2, manipulation of O2 mask or BiPAP mask, defibrillation, chest compressions, insertion of nasogastric tube, and collection of sputum were not significant. Our findings suggest that some procedures potentially capable of generating aerosols have been associated with increased risk of SARS transmission to HCWs or were a risk factor for transmission, with the most consistent association across multiple studies identified with tracheal intubation.


BMC Infectious Diseases | 2011

Clinical effectiveness of rapid tests for methicillin resistant Staphylococcus aureus (MRSA) in hospitalized patients: a systematic review

Julie Polisena; Stella Chen; Karen Cimon; Sarah McGill; Kevin R. Forward; Michael Gardam

BackgroundMethicillin resistant Staphylococcus aureus (MRSA) are often resistant to multiple classes of antibiotics. The research objectives of this systematic review were to evaluate the clinical effectiveness of polymerase chain reaction (PCR) versus chromogenic agar for MRSA screening, and PCR versus no screening for several clinical outcomes, including MRSA colonization and infection rates.MethodsAn electronic literature search was conducted on studies evaluating polymerase chain reaction techniques and methicillin (also spelled meticillin) resistant Staphylococcus aureus that were published from 1993 onwards using Medline, Medline In-Process & Other Non-Indexed Citations, BIOSIS Previews, and EMBASE. Due to the presence of heterogeneity in the selected studies, the clinical findings of individual studies were described.ResultsNine studies that compared screening for MRSA using PCR versus screening using chromogenic agar in a hospital setting, and two studies that compared screening using PCR with no or targeted screening were identified. Some studies found lower MRSA colonization and acquisition, infection, and transmission rates in screening with PCR versus screening with chromogenic agar, and the turnaround time for screening test results was lower for PCR. One study reported a lower number of unnecessary isolation days with screening using PCR versus screening with chromogenic agar, but the proportion of patients isolated was similar between both groups. The turnaround time for test results and number of isolation days were lower for PCR versus chromogenic agar for MRSA screening.ConclusionsThe use of PCR for MRSA screening demonstrated a lower turnaround time and number of isolation days compared with chromogenic agar. Given the mixed quality and number of studies (11 studies), gaps remain in the published literature and the evidence remains insufficient. In addition to screening, factors such as the number of contacts between healthcare workers and patients, number of patients attended by one healthcare worker per day, probability of colonization among healthcare workers, and MRSA status of hospital shared equipment and hospital environment must be considered to control the transmission of MRSA in a hospital setting.


Immunology and Allergy Clinics of North America | 2008

Economic Assessment of Different Modalities of Immunoglobulin Replacement Therapy

Stephen K Membe; Chuong Ho; Karen Cimon; Andra Morrison; Amin Kanani; Chaim M. Roifman

The delivery (intravenous or subcutaneous), location (home or hospital), and other factors of immunoglobulin replacement therapy are examined for cost effectiveness. Cost-minimization studies from several countries are reviewed and analyzed. A Canadian cost-minimization study is performed. Although common themes emerge, there are cost differences between the various countries.


Systematic Reviews | 2013

Post-marketing surveillance in the published medical and grey literature for percutaneous transluminal coronary angioplasty catheters: a systematic review

Julie Polisena; Alan J. Forster; Karen Cimon; Danielle Rabb

BackgroundPost-marketing surveillance (PMS) may identify rare serious incidents or adverse events due to the long-term use of a medical device, which was not captured in the pre-market process. Percutaneous transluminal coronary angioplasty (PTCA) is a non-surgical procedure that uses a balloon-tipped catheter to enlarge a narrowed artery. In 2011, 1,942 adverse event reports related to the use of PTCA catheters were submitted to the FDA by the manufacturers, an increase from the 883 reported in 2008. The primary research objective is to conduct a systematic review of the published and grey literature published between 2007 and 2012 for the frequency of incidents, adverse events and malfunctions associated with the use of PTCA catheters in patients with coronary artery disease (CAD). Grey literature has not been commercially published.MethodsWe searched MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials and PubMed for medical literature on PMS for PTCA catheters in patients with CAD published between January 2007 and July 2012. We also searched the grey literature.ResultsThis review included 11 studies. The in-hospital adverse events reported were individual cases of myocardial infarction and hematoma. In studies of patients with coronary perforation, more patients with balloon angioplasty were identified compared with patients who required stenting.ConclusionsOur systematic review illustrates that the volume and quality of PMS studies associated with the use of PTCA catheters in patients with CAD are low in the published and grey literature, and may not be useful sources of information for decisions on safety. In most studies, the objectives were not to monitor the long-term safety of the use of PTCA catheters in clinical practice. Future studies can explore the strengths and limitations of PMS databases administered by regulatory authorities.


Archive | 2011

Robot-Assisted Surgery Compared with Open Surgery and Laparoscopic Surgery: Clinical Effectiveness and Economic Analyses

Chuong Ho; Eva Tsakonas; Khai Tran; Karen Cimon; Melissa Severn; Monika Mierzwinski-Urban; Jacques Corcos; Stephen Pautler


PLOS ONE | 2015

Characteristics of included studies

Khai Tran; Kathryn Coyle; Mohammed F. Jabr; Doug Coyle; Michel Boucher; Lisa Mielniczuk; John R. Swiston; Danielle Rabb; Karen Cimon; Julie Blouin; Michael Innes


Open Medicine | 2007

Safety and effectiveness of point-of-care monitoring devices in patients on oral anticoagulant therapy: a meta-analysis

Phil Wells; Allan Brown; James Jaffey; Lynda McGahan; Man-Chiu Poon; Karen Cimon

Collaboration


Dive into the Karen Cimon's collaboration.

Top Co-Authors

Avatar

Khai Tran

Canadian Agency for Drugs and Technologies in Health

View shared research outputs
Top Co-Authors

Avatar

Mohammed F. Jabr

Canadian Agency for Drugs and Technologies in Health

View shared research outputs
Top Co-Authors

Avatar

Danielle Rabb

Canadian Agency for Drugs and Technologies in Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John R. Swiston

University of British Columbia

View shared research outputs
Top Co-Authors

Avatar

Julie Blouin

Canadian Agency for Drugs and Technologies in Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michel Boucher

Canadian Agency for Drugs and Technologies in Health

View shared research outputs
Top Co-Authors

Avatar

Kathryn Coyle

Brunel University London

View shared research outputs
Top Co-Authors

Avatar

Michael Innes

University of Birmingham

View shared research outputs
Researchain Logo
Decentralizing Knowledge